# A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye

> **NCT01743729** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 720 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Lifitegrast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01743729
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-07
- **Primary completion:** 2013-10-01
- **Final completion:** 2013-10-01
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2021-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01743729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01743729, "A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01743729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*